In HF2303 tumor cells, inhibition of HSP27 did decrease SPARC expression by 50%, but the decrease in both SPARC and HSP27 was not sufficient to decrease pAKT levels, suggesting additional pathways independently governing pAKT expression in these cells. The gene discussed is SPARC; the disease is neoplasm.